During the past decade, Hawaii Oncology Inc-Kuakini conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 31 clinical trials were completed, i.e. on average, 147.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 25 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hawaii Oncology Inc-Kuakini" #1 sponsor was "SWOG Cancer Research Network" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hawaii Oncology Inc-Kuakini" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hawaii Oncology Inc-Kuakini" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (3 trials), "Clear Cell Renal Cell Carcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hawaii Oncology Inc-Kuakini" in a lesser frequency.

Most popular intervention types in "Hawaii Oncology Inc-Kuakini" are "Drug" (34 trials), "Other" (27 trials), "Biological" (11 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Docetaxel" (5 trials), "Quality-of-Life Assessment" (5 trials), "Pharmacological Study" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hawaii Oncology Inc-Kuakini" are 30 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hawaii Oncology Inc-Kuakini". undefined are not yet recruiting, 1 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Hawaii Oncology Inc-Kuakini, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hawaii Oncology Inc-Kuakini, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".